| Ticker |
HIMS
|
| CIK | 0001773751 |
| SIC | 8011 |
| Sector | Services |
| Industry Category | Healthcare |
| Industry Group | Services – Health |
| Address | 2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123 |
| Website | forhims.com |
| Phone | 415-851-0195 |
| CEO | Andrew Dudum |
| Employees | 650 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Hims & Hers Health Is Looking to Cash In on This Novo Nordisk BlunderThe company will offer a generic version of semaglutide in the country after Novo Nordisk let its patent expire there. Hims & Hers Health (NYSE: HIMS) is a top telehealth stock that has been growing its business rapidly in recent years. Recently, it's looking to take advantage of an opportunity that has opened up as a result of a costly mistake that drugmaker Novo Nordisk (NYSE: NVO) has made. Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should KnowHims & Hers Health, Inc. (HIMS) reached $50.46 at the closing of the latest trading day, reflecting a -3.02% change compared to its last close. Hims & Hers Health, Inc. (HIMS) Announces Expansion To CanadaHims & Hers Health, Inc. (NYSE:HIMS) is among the 13 Best Booming Stocks to Buy Now. On July 9, the digital health and wellness platform announced plans to expand in Canada by offering generic semaglutide. This comes at a time when Novo Nordisk is set to lose its patent protection on Ozempic and Wegovy in Canada […] Hims (HIMS) Jumps 8.6% as Firm Still Open to Work With NovoWe recently published Market on Mute? Not for These 10 Stocks With Surprising Gains. Hims & Hers Health, Inc. (NYSE:HIMS) is one of Monday’s top performers. Hims & Hers bounced back by 8.64 percent on Monday to close at $52.03 following announcements that it remains open to working with Novo Nordisk in the future despite […] High Insider Ownership Fuels Growth Stocks In July 2025In July 2025, the U.S. markets have been experiencing mixed movements as inflation data and earnings reports from major financial institutions influence investor sentiment. Despite these fluctuations, major indices like the Nasdaq Composite continue to reach record highs, driven by strong performances in the tech sector. In this environment, growth companies with high insider ownership can offer unique insights into potential investment opportunities as insiders who hold significant stakes... |
